Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN16474818) titled 'Enterosgel(R) in the treatment of functional abdominal pain in children and young people' on May 21.
Study Type: Interventional
Study Design:
Multicentre interventional double-blinded randomized controlled trial (Quality of life, Treatment, Safety, Efficacy)
Primary Sponsor: Enteromed Ltd
Condition:
Treatment of abdominal pain in children and young people with Functional abdominal pain disorders.
Digestive System
Intervention:
The intervention is Enterosgel(R) an intestinal adsorbent classified as a medical device class IIA since 2011 in Europe. Currently indicated for symptomatic treatment of acute diarrhoe...